Virchows Archiv

, Volume 472, Issue 3, pp 505–512 | Cite as

Cellular subtype may predict survival outcomes in salivary adenoid cystic carcinoma patients—a single-institution experience

  • Ehab Y. Hanna
  • Ahmed S. A. Abdelmeguid
  • Dianna Roberts
  • Achim H. Bell
  • Randal S. Weber
  • Diana Bell
Brief Report

Notes

Acknowledgements

This work was supported by MD Anderson start-up funds (DB).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This retrospective, single-institution study was approved by MD Anderson’s Institutional Review Board.

References

  1. 1.
    Speight PM, Barrett AW (2002) Salivary gland tumours. Oral Dis 8:229–240CrossRefPubMedGoogle Scholar
  2. 2.
    Adenoid cystic carcinoma (2017). In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of tumors of the head and neck, 4th ed. Tumors of salivary glands. Lyon:IARC Press; 164–165Google Scholar
  3. 3.
    Bell D, Hanna EY (2013) Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment? Curr Opin Otolaryngol Head Neck Surg 21:124–129CrossRefPubMedGoogle Scholar
  4. 4.
    Barsky SH, Karlin NJ (2005) Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia 10:249–260CrossRefPubMedGoogle Scholar
  5. 5.
    Hu M, Yao J, Carroll DK et al (2008) Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 13:394–406CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Bell D, Bell AH, Bondaruk J, Hanna EY, Weber RS (2016) In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer 122:1513–1522CrossRefPubMedGoogle Scholar
  7. 7.
    Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK (2011) Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther 12:569–573CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Bell D, Roberts D, Kies M, Rao P, Weber RS, El-Naggar AK (2010) Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications. Cancer 116:5749–5756CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Lloyd S, JB Y, Wilson LD, Decker RH (2011) Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 34:76–81CrossRefPubMedGoogle Scholar
  10. 10.
    Hu Z, Fan C, DS O et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747–752CrossRefPubMedGoogle Scholar
  12. 12.
    Prat A, Perou CM (2011) Deconstructing the molecular portraits of breast cancer. Mol Oncol 5:5–23CrossRefPubMedGoogle Scholar
  13. 13.
    Raouf A, Zhao Y, To K et al (2008) Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3:109–118CrossRefPubMedGoogle Scholar
  14. 14.
    Weigelt B, Hu Z, He X et al (2005) Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res 65:9155–9158CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  1. 1.Department of Head and Neck SurgeryThe University of Texas MD Anderson Cancer CenterHoustonUSA
  2. 2.Department of PathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations